Barbara Zink - Basilea Pharmaceutica Insider

BPMUF -- USA Stock  

USD 67.13  0.005  0.0074%

We currently do not have informatin regarding Barbara Zink. This executive tanure with Basilea Pharmaceutica AG is not currenlty determined.
41 61 606 11 11

Management Efficiency

The company has return on total asset (ROA) of (2.6) % which means that it has lost $2.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (4.6) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 197.99 M in total debt. Basilea Pharmaceutica AG has Current Ratio of 3.62 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Basilea Pharmaceutica AG, together with its subsidiaries, operates as an integrated biopharmaceutical company. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. Basilea Pharmaceutica operates under Biotechnology classification in USA and traded on OTC Market. It employs 228 people.Basilea Pharmaceutica AG (BPMUF) is traded on OTC Market in USA. It is located in Grenzacherstrasse 487 and employs 228 people.

Basilea Pharmaceutica AG Leadership Team

Thomas Rinderknecht, Member of the Board of Directors
Marc Engelhardt, Member of the Management, Chief Medical Officer
Daniel Lew, Member of the Board of Directors
Martin Nicklasson, Chairman of the Board of Directors
Domenico Scala, Member of the Board of Directors
David Veitch, Chief Commercial Officer, Member of the Management Committee
Donato Spota, CFO
Guenter Ditzinger, CTO, Member of the Management Committee
Barbara Zink, Head - Corporate Development
Achim Kaufhold, Member of the Management Committee, Chief Medical Officer
Ronald Scott, CEO
Nicole Onetto, Member of the Board of Directors
Alf Nicklasson, Member of the Board of Directors
Heidi McDaid, Head of Global HR
Anne Stehlin, Member of the Management Board, Head of Global Quality Management
Thomas Werner, Member of the Board of Directors
Ingrid HeinzeKrauss, Member of the Management Committee, CTO
Laurenz Kellenberger, Chief Scientific Officer
Steven Skolsky, Member of the Board of Directors
HansBeat Guertler, Member of the Board of Directors
Peer Schroeder, Head of Corporate Communications & Investor Relations

Stock Performance Indicators

Did you try this?

Run Global Markets Map Now

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Global Markets Map

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Basilea Pharmaceutica and Apple. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.